BUDESONIDE/FORMOTEROL MAINTENANCE AND RELIEVER THERAPY: AN EFFECTIVE ASTHMA TREATMENT OPTION? EUR RESPIR J 2005; 26: 819-828.
P.K. Myint, R.N. Luben, P.G. Surtees, N.W.J. Wainwright, A.A. Welch, S.A. Bingham, N.J. Wareham, N.E. Day and K-T. Khaw., C. VOGELMEIER, A. D'URZO, R. PAUWELS, J.M. MERINO, M. JASPAL, S. BOUTET, I. NAYA AND D. PRICE.
Source: Eur Respir J 2005; 26: 1191
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P.K. Myint, R.N. Luben, P.G. Surtees, N.W.J. Wainwright, A.A. Welch, S.A. Bingham, N.J. Wareham, N.E. Day and K-T. Khaw., C. VOGELMEIER, A. D'URZO, R. PAUWELS, J.M. MERINO, M. JASPAL, S. BOUTET, I. NAYA AND D. PRICE.. BUDESONIDE/FORMOTEROL MAINTENANCE AND RELIEVER THERAPY: AN EFFECTIVE ASTHMA TREATMENT OPTION? EUR RESPIR J 2005; 26: 819-828.. Eur Respir J 2005; 26: 1191
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD. EUR RESPIR J 2005; 26: 406-413. Source: Eur Respir J 2006; 27: 440 Year: 2006
IMPACT OF SMOKE-FREE WORKPLACE LEGISLATION ON EXPOSURES AND HEALTH: POSSIBILITIES FOR PREVENTION. M.S. JAAKKOLA AND J.J.K. JAAKKOLA. EUR RESPIR J 2006; 28: 397-408. Source: Eur Respir J 2006 Oct 01;28(4):887-888 Year: 2006
EXCLUSION OF ACTIVE MYCOBACTERIUM TUBERCULOSIS COMPLEX INFECTION WITH THE T-SPOTTM.TB ASSAY. R.M.L. VAN LEEUWEN, A.W.J. BOSSINK AND S.F.T. THIJSEN. EUR RESPIR J 2007; 29: 605-607. Source: Eur Respir J 2007; 29: 1286 Year: 2007
"BECLOMETHASONE/FORMOTEROL VERSUS BUDESONIDE/FORMOTEROL COMBINATION THERAPY IN ASTHMA". A. PAPI, P.L. PAGGIARO, G. NICOLINI, A.M. VIGNOLA AND L.M. FABBRI ON BEHALF OF THE INHALED COMBINATION ASTHMA TREATMENT VERSUS SYMBICORT (ICAT SY) STUDY GROUP. EUR RESPIR J 2007; 29: 682-689. Source: Eur Respir J 2008; 32: 822 Year: 2008
"TACROLIMUS FOR ANTISYNTHETASE SYNDROME WITH INTERSTITIAL LUNG DISEASE?" [REPLY LETTER]. L.P. NICOD. EUR RESPIR J 2008; 32: 245-246. Source: Eur Respir J 2008; 32: 822 Year: 2008
"PROGRESSION OF SNORING AND OBSTRUCTIVE SLEEP APNOEA: THE ROLE OF INCREASING WEIGHT AND TIME". G. BERGER, R. BERGER AND A. OKSENBERG. EUR RESPIR J 2009; 33: 338-345. Source: Eur Respir J 2009; 33: 947 Year: 2009
"FREQUENCY AND CLINICAL CHARACTERISTICS OF RAPID-ONSET FATAL AND NEAR-FATAL ASTHMA". V. PLAZA, J. SERRANO, C. PICADO, J. SANCHIS, ON BEHALF OF THE HIGH RISK ASTHMA RESEARCH GROUP. EUR RESPIR J 2002; 19: 846-852. Source: Eur Respir J 2009; 33: 1240 Year: 2009
"HOW MUCH IS TOO MUCH? THE TREATMENT OF MILD ASTHMA". P.M. O'BYRNE. EUR RESPIR J 2007; 30: 403 406. Source: Eur Respir J 2007; 30: 1026 Year: 2007
“ASSESSING THE TREATMENT EFFECT FROM MULTIPLE TRIALS IN IDIOPATHIC PULMONARY FIBROSIS.” L. RICHELDI. EUR RESPIR REV 2012; 21: 147–151. Source: Eur Respir Rev 2012 21:263 Year: 2012
EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. B.R. CELLI AND P.J. BARNES. EUR RESPIR J 2007; 29: 1224 1238. Source: Eur Respir J 2007; 30: 401 Year: 2007
INVASIVE PULMONARY ASPERGILLOSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. P. BULPA, A. DIVE AND Y. SIBILLE. EUR RESPIR J 2007; 30: 782 800. Source: Eur Respir J 2007; 30: 1236 Year: 2007
BECLOMETHASONE/FORMOTEROL VERSUS BUDESONIDE/FORMOTEROL COMBINATION THERAPY IN ASTHMA. A. PAPI, P.L. PAGGIARO, G. NICOLINI, A.M. VIGNOLA AND L.M. FABBRI ON BEHALF OF THE INHALED COMBINATION ASTHMA TREATMENT VERSUS SYMBICORT (ICAT SY) STUDY GROUP. EUR Source: Eur Respir J 2007; 29: 1286 Year: 2007
"REDUCED MITOCHONDRIAL DENSITY IN THE VASTUS LATERALIS MUSCLE OF PATIENTS WITH COPD". H.R. GOSKER, M.K.C. HESSELINK, H. DUIMEL, K.A. WARD AND A.M.W.J. SCHOLS. EUR RESPIR J 2007; 30: 73 79. Source: Eur Respir J 2007; 30: 817 Year: 2007
ANTIBIOTICS FOR CHRONIC BRONCHITIS: A META-ANALYSIS THAT SPEAKS ONLY FOUR LANGUAGES. M. MIRAVITLLES, B. CELLI AND A. ANZUETO. EUR RESPIR J 2007; 30: 815. Source: Eur Respir J 2007; 30: 1236 Year: 2007
CARDIOVASCULAR RISK (CVR) AND EFFECTS ON THE QUALITY OF LIFE AFTER A PHYSICAL REHABILITATION PROGRAM ON COPD PATIENTS BASED ON THEIR PHENOTYPE: EXACERBATOR (E) OR NON-EXACERBATOR (NE) Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
NON-CYSTIC FIBROSIS (CF) BRONCHIECTASIS: A 5-YEAR RETROSPECTIVE STUDY WITH A FOCUS ON PATIENTS WITH PRIMARY IMMUNODEFICIENCIES (PID) Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018
"LUNG VOLUME MEASUREMENTS" [REPLY LETTER]. M. CAZZOLA, V. BRUSASCO AND F.J. MARTINEZ. EUR RESPIR J 2008; 32: 528. Source: Eur Respir J 2008; 32: 822 Year: 2008
"PREMATURE DISCONTINUATION OF PATIENTS: A POTENTIAL BIAS IN COPD CLINICAL TRIALS". S. KESTEN, M. PLAUTZ, C.A. PIQUETTE, M.P. HABIB AND D.E. NIEWOEHNER. SO - Eur Respir J 2007; 30: 898 906. Source: Eur Respir J 2008; 31: 226 Year: 2008
EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES. Source: International Congress 2019 – Clinical approach to asthma management Year: 2019
"ENVIRONMENTAL TEMPERATURE AND RELATIVE HUMIDITY INFLUENCE EXHALED BREATH CONDENSATE PH". T. KULLMANN, I. BARTA, B. ANTUS, M. VALYON AND I. HORVATH. EUR RESPIR J 2008; 31: 474-475. Source: Eur Respir J 2008; 31: 912 Year: 2008